利用尿液药物检测在临床护理中支持健康的界限。

Using urine drug testing to support healthy boundaries in clinical care.

作者信息

Heit Howard A, Gourlay Douglas L

机构信息

Assistant Clinical Professor, Department of Medicine, Georgetown University, Arlington, Virginia.

University of Toronto, Toronto, Ontario, Canada.

出版信息

J Opioid Manag. 2015 Jan-Feb;11(1):7-12. doi: 10.5055/jom.2015.0247.

DOI:10.5055/jom.2015.0247

PMID:25750160

Abstract

Risk management is first and foremost about protecting patients. This article will examine risk management in general, and urine drug testing (UDT) in particular, as core constituents in an effective, comprehensive risk management strategy. The article will explore UDT as a tool to help practitioners and patients make better choices in the clinical management of chronic pain. How one makes these difficult clinical decisions based on UDT results as well common barriers encountered in conducting patient-centered UDT will also be examined.

摘要

风险管理首先也是最重要的是保护患者。本文将探讨一般的风险管理，特别是尿液药物检测（UDT），将其作为有效、全面的风险管理策略的核心组成部分。本文将探讨UDT作为一种工具，帮助从业者和患者在慢性疼痛的临床管理中做出更好的选择。还将研究如何根据UDT结果做出这些艰难的临床决策，以及在开展以患者为中心的UDT过程中遇到的常见障碍。